All News

ExsoMed Corporation Announces FDA 510(k) Clearance of InFrame™ Intramedullary Micro Nail for Proximal Phalanx Fractures

ALISO VIEJO, CALIF. (PRWEB) SEPTEMBER 01, 2020 ExsoMed Corporation, a privately held U.S.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, received 510(k) clearance from the United States Food and Drug Administration to commercialize its InFrame Intramedullary Micro Nail. The threaded micro nail provides surgeons with a simple, minimally invasive solution to …

Stryker’s AxSOS 3® Ankle Fusion System Offers Innovative Plates That Are Designed to Fit a Range of Patients

September 1, 2020 MAHWAH, N.J.–(BUSINESS WIRE)–Stryker’s Trauma & Extremities division today announced the launch of its AxSOS 3Ankle Fusion System, an ankle fusion titanium plate system intended for the fusion of the tibio-talar joint. The AxSOS 3 Ankle Fusion System was developed using SOMA, Stryker’s proprietary orthopaedic design and development system that applies data from …

First-Ever Study on Hepatitis C as Predictor of Issues Following Lumbar Fusion

by Elizabeth Hofheinz, M.P.H., M.Ed. While many outcomes have been explored as far as lumbar fusion, until now, there has been no data on how Hepatitis C virus affects outcomes. A new retrospective review has examined in-hospital lengths of stay (LOS), post-operative complications, readmission rates or costs following primary posterior lumbar fusions. Co-author Alexander Vaccaro, …

CMS’ requirement of a positive COVID-19 test for 20% bonus may be burdensome for hospitals

August 31, 2020 / Jeff Lagasse, Associate Editor While the effects of COVID-19 on the human body are still being studied, one thing that’s clear is that many patients who survive coronavirus-related hospitalizations still have a substantial need for post-acute care services. But a problem arose: Hospitals that continue to treat patients who no longer meet …

Kuros Biosciences Announces Treatment of the First Patient in its Spinal Fusion Trial with Fibrin-PTH

SCHLIEREN (ZURICH), Switzerland, Sept. 01, 2020 (GLOBE NEWSWIRE) — Kuros Biosciences, a leader in next generation bone graft technologies, today announced that the first patient has been treated in the STRUCTURE trial, investigating Fibrin-PTH (KUR-113) for transforaminal lumbar interbody fusion (TLIF) procedures in patients with degenerative disc disease. The first patient was treated by Dr. Richard …

Royal Biologics Announces the Acquisition of FIBRINET

HACKENSACK, N.J., Sept. 1, 2020 /PRNewswire/ — Royal Biologics, an ortho-biologics company specializing in the research and advancement of autologous and live cellular solutions, today announced the completed acquisition of FIBRINET, from Vertical Spine LLC. The acquisition comes as part of Royal Biologics’ strategic initiative to add novel technologies to its growing portfolio of autologous and live cellular …

Tsunami Medical appoints Peter Witke as Chief Commercial Officer

Modena, September 1st 2020 Tsunami Medical, one of the leaders in Spine technology innovation, focusing on 3D printed solutions for Spine surgery diagnostic invasive procedures, today announced the appointment of Peter Witke as Chief Commercial Officer (CCO), effective immediately. Mr. Witke brings more than 28 years of experience in sales, marketing, business development, strategy and …

“Significant” Increases in Morbidity, Mortality in Hip Fracture Patients with COVID-19

by Elizabeth Hofheinz, M.P.H., M.Ed. A recent article from Tufts Medical Center has explored the evolving interplay between orthopedic trauma and COVID-19. The study, “Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients With COVID-19: A Review of the Current Evidence and Our Surgical Experience,” appears in the May 14, 2020 edition of …

Stimulus Deal Getting Closer, But There’s More Work To Be Done

August 31, 2020 / Rob Berger, Senior Contributor Only in Washington can politicians slowly make progress toward a stimulus deal while pounding the table and accusing the other side of being unreasonable. Yet even with negotiations over the next stimulus package at a standstill, the two sides moved $500 billion closer to a deal last …

Hospital revenue at risk in CMS’ proposal to move joint replacement to outpatient care

August 29, 2020 / Susan Morse, Managing Editor The Centers for Medicare and Medicaid Services’ push to move procedures from inpatient to less expensive outpatient care continues, with revenue at risk for lucrative joint replacement starting in 2021. CMS’s continued push to the outpatient setting has been going on for some time, but the agency has …

© 2022 MedDeviceJobs.com Powered by Careerleaf
v.3.8.5